MAb to Francisella tularensis lipopolysaccharide

被引：0
|
作者：
Berry, Jody D. [1 ]
机构：
[1] Publ Hlth Agcy Canada, Natl Microbiol Lab, Emerging Bacterial Pathogens Div, Winnipeg, MB R3E 3R2, Canada
[2] Publ Hlth Agcy Canada, Natl Microbiol Lab, Monoclonal Antibody Sect, Winnipeg, MB R3E 3R2, Canada
来源：
HYBRIDOMA | 2007年 / 26卷 / 02期
关键词：
D O I：
10.1089/hyb.2007.9995
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
[No abstract available]
引用
收藏
页码：109 / 109
页数：1
相关论文
共 50 条
  • [1] Structural analysis of Francisella tularensis lipopolysaccharide
    Vinogradov, E
    Perry, MB
    Conlan, JW
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 2002, 269 (24): : 6112 - 6118
  • [2] Differential effects of Francisella tularensis lipopolysaccharide on B lymphocytes
    Rahhal, Riad M.
    Bush, Tony J. Vanden
    McLendon, Molly K.
    Apicella, Michael A.
    Bishop, Gail A.
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 2007, 82 (04) : 813 - 820
  • [3] Production and characterization of a monoclonal antibody to Francisella tularensis lipopolysaccharide
    Gubbins, Michael J.
    Berry, Jody D.
    Schmidt, Lisa
    Cabral, Teresa
    Kabani, Amin
    Tsang, Raymond S.
    [J]. HYBRIDOMA, 2007, 26 (02): : 98 - 103
  • [4] IMMUNOGENICITY AND TOXICITY OF LIPOPOLYSACCHARIDE FROM FRANCISELLA-TULARENSIS LVS
    SANDSTROM, G
    SJOSTEDT, A
    JOHANSSON, T
    KUOPPA, K
    WILLIAMS, JC
    [J]. FEMS MICROBIOLOGY IMMUNOLOGY, 1992, 105 (04): : 201 - 210
  • [5] ACTIVATION OF THE COMPLEMENT-SYSTEM BY FRANCISELLA-TULARENSIS LIPOPOLYSACCHARIDE
    FULOP, M
    WEBBER, T
    MANCHEE, R
    [J]. MICROBIOLOGICA, 1993, 16 (02): : 141 - 148
  • [6] PREVENTIVE ACTIVITY OF MONOCLONAL-ANTIBODIES TO FRANCISELLA-TULARENSIS LIPOPOLYSACCHARIDE
    KHLEBNIKOV, VS
    VETCHININ, SS
    GRECHKO, GK
    AVERINA, AA
    GOLOVLEV, IP
    AVERIN, SF
    ZHEMCHUGOV, VE
    KONOVALOV, SI
    ANISIMOV, GA
    AFANASYEV, SS
    [J]. ZHURNAL MIKROBIOLOGII EPIDEMIOLOGII I IMMUNOBIOLOGII, 1992, (9-10): : 67 - 70
  • [7] Development of Immunoassays for Detection of Francisella tularensis Lipopolysaccharide in Tularemia Patient Samples
    Hannah, Emily E.
    Pandit, Sujata G.
    Hau, Derrick
    DeMers, Haley L.
    Robichaux, Kayleigh
    Nualnoi, Teerapat
    Dissanayaka, Anjana
    Arias-Umana, Jose
    Green, Heather R.
    Thorkildson, Peter
    Pflughoeft, Kathryn J.
    Gates-Hollingsworth, Marcellene A.
    Ozsurekci, Yasemin
    AuCoin, David P.
    [J]. PATHOGENS, 2021, 10 (08):
  • [8] Basis for the failure of Francisella tularensis lipopolysaccharide to prime human polymorphonuclear leukocytes
    Barker, Jason H.
    Weiss, Jerrold
    Apicella, Michael A.
    Nauseef, William M.
    [J]. INFECTION AND IMMUNITY, 2006, 74 (06) : 3277 - 3284
  • [9] Francisella tularensis vaccines
    Griffin, Kate F.
    Oyston, Petra C. F.
    Titball, Richard W.
    [J]. FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2007, 49 (03): : 315 - 323
  • [10] FRANCISELLA TULARENSIS - REVIEW
    Cieslik, Piotr
    Knap, Jozef
    Bielawska-Drozd, Agata
    [J]. POSTEPY MIKROBIOLOGII, 2018, 57 (01): : 58 - 67
12345